Package 27241-239-01

Brand: oxcarbazepine

Generic: oxcarbazepine
NDC Package

Package Facts

Identity

Package NDC 27241-239-01
Digits Only 2724123901
Product NDC 27241-239
Product ID 27241-239_ffbd0c62-0cbd-4ea3-b1a1-1a40a16884e3
Description

100 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-239-01)

Marketing

Marketing Status
Marketed Since 2024-02-22
Brand oxcarbazepine
Generic oxcarbazepine
Sample Package No

Linked Drug Pages (1)

Oxcarbazepine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "ffbd0c62-0cbd-4ea3-b1a1-1a40a16884e3", "openfda": {"nui": ["N0000175753", "N0000008486"], "upc": ["0327241238017", "0327241239014", "0327241237010"], "unii": ["VZI5B1W380"], "rxcui": ["1365653", "1365842", "1365844"], "spl_set_id": ["d947e9b1-2a15-4048-bb4e-fe56b6851848"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Ajanta Pharma USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-239-01)", "package_ndc": "27241-239-01", "marketing_start_date": "20240222"}], "brand_name": "Oxcarbazepine", "product_id": "27241-239_ffbd0c62-0cbd-4ea3-b1a1-1a40a16884e3", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "27241-239", "generic_name": "Oxcarbazepine", "labeler_name": "Ajanta Pharma USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Oxcarbazepine", "active_ingredients": [{"name": "OXCARBAZEPINE", "strength": "600 mg/1"}], "application_number": "ANDA217659", "marketing_category": "ANDA", "marketing_start_date": "20240222", "listing_expiration_date": "20271231"}